Search research articles
Contact Us
Filters
Showing results (201-210 of 237) with videos related to
Page
of 24
Sort By:
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma
Maryam Safari, Luigi Scotto, Agnes Basseville, et al.
The Journal of Clinical Investigation
|
October 16, 2023
Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment
Eunhyeong Lee, Sophie O'Keefe, Alessandra Leong, et al.
Cancer Medicine
|
March 9, 2021
Long-term outcomes in patients with advanced adrenocortical carcinoma after image-guided locoregional ablation or embolization
Michal Mauda-Havakuk, Elizabeth Levin, Elliot B Levy, et al.
European Radiology
|
June 27, 2023
Ethnic diversity in treatment response for colorectal cancer: proof of concept for radiomics-driven enrichment trials
Laurent Dercle, Melissa Yang, Mithat Gönen, et al.
Molecular Cancer Therapeutics
|
October 16, 2004
Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin
Frank Loganzo, Malathi Hari, Tami Annable, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2013
Phase I trial of a new schedule of romidepsin in patients with advanced cancers
Laleh Amiri-Kordestani, Victoria Luchenko, Cody J Peer, et al.
Seminars in Oncology
|
November 24, 2019
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide
Harshraj Leuva, Keith Sigel, Mengxi Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2010
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer
Ronan J Kelly, Deborah Draper, Clara C Chen, et al.
Anti-Cancer Drugs
|
February 9, 2018
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung
Sanjeeve Balasubramaniam, Christophe E Redon, Cody J Peer, et al.
The Oncologist
|
November 11, 2022
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data
Celine Yeh, Mengxi Zhou, Keith Sigel, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 237) with videos related to
Sort By:
Page
of 24
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma
Maryam Safari, Luigi Scotto, Agnes Basseville, et al.
The Journal of Clinical Investigation
|
October 16, 2023
Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment
Eunhyeong Lee, Sophie O'Keefe, Alessandra Leong, et al.
Cancer Medicine
|
March 9, 2021
Long-term outcomes in patients with advanced adrenocortical carcinoma after image-guided locoregional ablation or embolization
Michal Mauda-Havakuk, Elizabeth Levin, Elliot B Levy, et al.
European Radiology
|
June 27, 2023
Ethnic diversity in treatment response for colorectal cancer: proof of concept for radiomics-driven enrichment trials
Laurent Dercle, Melissa Yang, Mithat Gönen, et al.
Molecular Cancer Therapeutics
|
October 16, 2004
Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin
Frank Loganzo, Malathi Hari, Tami Annable, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2013
Phase I trial of a new schedule of romidepsin in patients with advanced cancers
Laleh Amiri-Kordestani, Victoria Luchenko, Cody J Peer, et al.
Seminars in Oncology
|
November 24, 2019
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide
Harshraj Leuva, Keith Sigel, Mengxi Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2010
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer
Ronan J Kelly, Deborah Draper, Clara C Chen, et al.
Anti-Cancer Drugs
|
February 9, 2018
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung
Sanjeeve Balasubramaniam, Christophe E Redon, Cody J Peer, et al.
The Oncologist
|
November 11, 2022
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data
Celine Yeh, Mengxi Zhou, Keith Sigel, et al.
Page
of 24